期刊
TRANSLATIONAL ANDROLOGY AND UROLOGY
卷 7, 期 5, 页码 831-843出版社
AME PUBL CO
DOI: 10.21037/tau.2018.08.03
关键词
Positron emission tomography/computed tomography (PET/CT); nuclear medicine; prostatic neoplasms; tomography; emission-computed, single-photon; gallium
资金
- Intramural Research Program of the National Institutes of Health
- National Cancer Institute, National Institutes of Health [HHSN261200800001E]
- NATIONAL CANCER INSTITUTE [ZIABC010655] Funding Source: NIH RePORTER
Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) is an emerging prostate cancer imaging method, which has been reported to have a higher sensitivity and specificity than the currently approved PET imaging agents. Multiple PSMA ligands are being investigated around the world and applications range from primary tumor characterization, to local staging, biochemical recurrence, metastasis, and image-guided interventions. The most investigated PET tracers are labelled with 68-Gallium or 18-Fluoride and are discussed in this review. Additionally, Tc-99m labeled PSMA agents for single photon emission computed tomography (SPECT) imaging are elucidated as an alternative method of PSMA image acquisition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据